UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The genetics of type 2 diabetes: what have we learned from GWAS?

Annals of the New York Academy of Sciences, 2010-11, Vol.1212 (1), p.59-77

2010

Volltextzugriff (PDF)

Leveraging advances in diabetes technologies in primary care: a narrative review

Annals of medicine (Helsinki), 2021-01, Vol.53 (1), p.805-816

2021

Volltextzugriff (PDF)

The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study

Diabetes, obesity & metabolism, 2023-10, Vol.25 (10), p.2989-2998

2023

Volltextzugriff (PDF)

Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial

Diabetes care, 2018-05, Vol.41 (5), p.1009-1016

2018

Volltextzugriff (PDF)

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2021-04, Vol.325 (14), p.1403

2021

Volltextzugriff (PDF)

Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus

Metabolism, clinical and experimental, 2013-12, Vol.62 (12), p.1772-1778

2013

Volltextzugriff (PDF)

Statistical evidence for high‐penetrance MODY‐causing genes in a large population‐based cohort

Endocrinology, diabetes & metabolism, 2022-11, Vol.5 (6), p.e372-n/a

2022

Volltextzugriff (PDF)

GLP-1 RA and SGLT2 Inhibitors: In Harmony for Organ Protection

Journal of the American College of Cardiology, 2023-08, Vol.82 (6), p.526-528

2023

Volltextzugriff (PDF)

Transitioning from basal–bolus or premix insulin therapy to a combination of basal insulin and glucagon‐like peptide‐1 receptor agonist in people with type 2 diabetes

Diabetic medicine, 2022-09, Vol.39 (9), p.e14901-n/a

2022

Volltextzugriff (PDF)

Reclassification of coronary artery disease risk using genetic risk score among subjects with borderline or intermediate clinical risk

International journal of cardiology. Heart & vasculature, 2022-12, Vol.43, p.101136-101136, Article 101136

2022

Volltextzugriff (PDF)

Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program

Diabetes technology & therapeutics, 2018-08, Vol.20 (8), p.561-565

2018

Volltextzugriff (PDF)

Acute cytokine-mediated downregulation of the zinc transporter ZnT8 alters pancreatic β-cell function

Journal of endocrinology, 2010-08, Vol.206 (2), p.159-169

2010

Volltextzugriff (PDF)

689-P: Association of Preoperative Glycemic Response to GLP-1 Receptor Agonists (GLP-1RA) and Outcomes of Bariatric Surgery

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add‐on to sodium‐glucose co‐transporter‐2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes

Diabetes, obesity & metabolism, 2019-06, Vol.21 (6), p.1399-1408

2019

Volltextzugriff (PDF)

Effect of a Type 2 Diabetes-Focused Visit Improvement Initiative on Therapeutic Inertia and Glycemic Control in Primary Care

Clinical diabetes, 2023-04, Vol.41 (2), p.296-300

2023

Volltextzugriff (PDF)

Utility of Polygenic Scores for Differentiating Diabetes Diagnosis Among Patients With Atypical Phenotypes of Diabetes

The journal of clinical endocrinology and metabolism, 2023-12, Vol.109 (1), p.107-113

2023

Volltextzugriff (PDF)

Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 Diabetes

Journal of diabetes science and technology, 2024-05, Vol.18 (3), p.653-659

2024

Volltextzugriff (PDF)

Living with Chronic Kidney Disease and Type 2 Diabetes Mellitus: The Patient and Clinician Perspective

Advances in therapy, 2023-01, Vol.40 (1), p.1-18

2023

Volltextzugriff (PDF)

1687-P: An Examination of Clinical Outcomes in People with T1D and Obesity

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

Increased Genetic Risk for β-Cell Failure Is Associated With β-Cell Function Decline in People With Prediabetes

Diabetes (New York, N.Y.), 2024-08, Vol.73 (8), p.1352-1360

2024

Volltextzugriff (PDF)

Association of vitamin D deficiency with incidence of type 2 diabetes in high-risk Asian subjects

The American journal of clinical nutrition, 2013-03, Vol.97 (3), p.524-530

2013

Volltextzugriff (PDF)

Health-Related Quality of Life Assessments with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus

Journal of managed care & specialty pharmacy, 2018-09, Vol.24 (9-a Suppl), p.S30-S41

2018

Volltextzugriff (PDF)

Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin‐treated adults with type 2 diabetes and risk factors for hypoglycaemia

Diabetes, obesity & metabolism, 2021-11, Vol.23 (11), p.2572-2581

2021

Volltextzugriff (PDF)

1124-P: Clinical and Genetic Models Assess the Probability of Type 1 Diabetes (T1D) among Patients with Nonclassic Diabetes Features

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

606-P: Higher Derived Time-in-Range with IDegLira vs. Insulin Glargine U100 in Patients with T2D

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(60)

Sprache

Englisch
(60)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Diabetes
(32)
Humans
(25)
Endocrinology & Metabolism
(24)
Diabetes Mellitus
(21)
Insulin
(20)
Diabetes Mellitus, Type 2 - Drug Therapy
(13)
Male
(13)
Middle Aged
(13)
Female
(12)
Glucose
(12)
Adult
(11)
Type 2 Diabetes
(11)
Metformin
(10)
Aged
(9)
Hypoglycemia
(9)
Hypoglycemic Agents - Therapeutic Use
(9)
Hypoglycemic Agents - Administration & Dosage
(8)
Blood Glucose
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The genetics of type 2 diabetes: what have we learned from GWAS?

Leveraging advances in diabetes technologies in primary care: a narrative review

The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study

Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial

Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus

Statistical evidence for high‐penetrance MODY‐causing genes in a large population‐based cohort

GLP-1 RA and SGLT2 Inhibitors: In Harmony for Organ Protection

Transitioning from basal–bolus or premix insulin therapy to a combination of basal insulin and glucagon‐like peptide‐1 receptor agonist in people with type 2 diabetes

Reclassification of coronary artery disease risk using genetic risk score among subjects with borderline or intermediate clinical risk

Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program

Acute cytokine-mediated downregulation of the zinc transporter ZnT8 alters pancreatic β-cell function

689-P: Association of Preoperative Glycemic Response to GLP-1 Receptor Agonists (GLP-1RA) and Outcomes of Bariatric Surgery

Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add‐on to sodium‐glucose co‐transporter‐2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes

Effect of a Type 2 Diabetes-Focused Visit Improvement Initiative on Therapeutic Inertia and Glycemic Control in Primary Care

Utility of Polygenic Scores for Differentiating Diabetes Diagnosis Among Patients With Atypical Phenotypes of Diabetes

Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 Diabetes

Living with Chronic Kidney Disease and Type 2 Diabetes Mellitus: The Patient and Clinician Perspective

1687-P: An Examination of Clinical Outcomes in People with T1D and Obesity

Increased Genetic Risk for β-Cell Failure Is Associated With β-Cell Function Decline in People With Prediabetes

Association of vitamin D deficiency with incidence of type 2 diabetes in high-risk Asian subjects

Health-Related Quality of Life Assessments with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus

Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin‐treated adults with type 2 diabetes and risk factors for hypoglycaemia

1124-P: Clinical and Genetic Models Assess the Probability of Type 1 Diabetes (T1D) among Patients with Nonclassic Diabetes Features

606-P: Higher Derived Time-in-Range with IDegLira vs. Insulin Glargine U100 in Patients with T2D

Suchergebnisse filtern